Back to
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
MRTX22 quarters
Position history for
CHARLES SCHWAB INVESTMENT MANAGEMENT INC's holdings in MIRATI THERAPEUTICS INC
As of its Q4 2023 13F, Charles Schwab Investment Management held 365,428 shares of MRTX (Mirati Therapeutics), worth $21.5M. Charles Schwab Investment Management's 13F filings listed MRTX from Q4 2018 to Q4 2023, 21 quarterly filings.
Final Value
$0
Final Shares
0
Total Value Change
-$6.5M
Total Shares Change
-153,326
Quarter-by-Quarter History
Other major holders of MRTX: Avoro Capital Advisors LLC